Skip to main content
SpringerLink
Log in

Emergence and infectious complications of ciprofloxacin-resistantEscherichia coli in haematological cancer patients

  • Brief Reports
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dekker AW, Rozenberg-Arska M, Verhoef J: Infection Prophylaxis in acute leukaemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Annals of Internal Medicine (1987) 106:7–12

    Google Scholar 

  2. The GIMEMA Infection Program: Prevention of bacterial infection in neutropenic patients with haematological malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. Annals of Internal Medicine (1991) 115:7–12

    Google Scholar 

  3. Lew MA, Kehoe K, Ritz J, Antman KH, Nadler L, Takvorian T, Mayer R, Kalish L, Finberg R: Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. Transplantation (1991) 51:630–636

    Google Scholar 

  4. Cruciani M, Rampazzo R, Malena M, Lazzarini L, Todeschini G, Messori A, Concia E: Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta- analysis. Clinical Infectious Diseases (1996) 23:795–805

    Google Scholar 

  5. Lopez-Brea M, Alarcon T: Isolation of fluoroquinoloneresistantEscherichia coli andKlebsiella pneumonia from an infected Hickman catheter. European Journal of Clinical Microbiology & Infectious Diseases (1990) 9:345–347

    Google Scholar 

  6. Cometta A, Calandra T, Bille J, Glauser MP:Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. New England Journal of Medicine (1994) 330:1240–1241

    Google Scholar 

  7. Kern WF, Andriof E, Oethinger M, Kern P, Hacker J, Marre R: Emergence of fluoroquinolone-resistantEscherichia coli at a cancer center. Antimicrobial Agents and Chemotherapy (1994) 38:681–687

    Google Scholar 

  8. Carratala J, Fernandez-Sevilla A, Tubau F, Callis M, Gudiol F: Emergence of quinolone-resistantEscherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin. Clinical Infectious Diseases (1995) 20:557–560

    Google Scholar 

  9. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE: DNA diversity among clinical isolates ofHelicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Research (1992) 20:5137–5142

    Google Scholar 

  10. Versalovic J, Koeuth T, Lupski J: Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Research (1991) 24:6823–6831

    Google Scholar 

  11. Sato K, Inoue Y, Fujii T, Aoyama H, Inoue M, Mitsuhashi S: Purification and properties of DNA gyrase from a fluroquinolone-resistant strain ofEcherichia coli. Antimicrobial Agents and Chemotherapy (1986) 30:777–780

    Google Scholar 

  12. Wolfson JS, Hooper DC: Bacterial resistance to quinolones: mechanisms and clinical importance. Reviews of Infectious Diseases (1989) 11, Supplement 5:960–986

    Google Scholar 

  13. Crumplin GC: Mechanisms of resistance to the 4-quinolone antibacterial agents. Journal of Antimicrobial Chemotherapy (1990) 26, Supplement F: 131–144

    Google Scholar 

  14. Muder RR, Brennen C, Goetz AM, Wagener MM, Rihs JD: Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a veteran affairs medical center. Antimicrobial Agents and Chemotherapy (1991) 35:256–258

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, University Hospital Utrecht, Heidelberglaan 100, NL-3584, CX Utrecht, The Netherlands

    M. G. J. van Kraaij, A. W. Dekker & L. F. Verdonck

  2. Eijkman-Winkler Institute for Medical Microbiology, University Hospital Utrecht, Utrecht, The Netherlands

    E. Peters, A. Fluit & M. Rozenberg-Arska

Authors
  1. M. G. J. van Kraaij
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. W. Dekker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Fluit
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. F. Verdonck
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Rozenberg-Arska
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Kraaij, M.G.J., Dekker, A.W., Peters, E. et al. Emergence and infectious complications of ciprofloxacin-resistantEscherichia coli in haematological cancer patients. Eur. J. Clin. Microbiol. Infect. Dis. 17, 591–592 (1998). https://doi.org/10.1007/BF01708627

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01708627

Keywords

Search

Navigation